50 Studies Every Surgeon Should Know

ISBN : 9780199384075

SreyRam Kuy; Rachel J. Kwon; Michael E. Hochman; Miguel A. Burch
296 ページ
156 x 235 mm

50 Studies Every Surgeon Should Know presents key studies that have shaped the practice of surgery. Selected using a rigorous methodology, the studies cover topics including: vascular, colorectal, bariatric, abdominal, hernial, and endocrine surgery, surgical outcomes, surgical oncology, trauma and surgical critical care, and studies of historical interest. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for health care professionals and anyone who wants to learn more about the data behind clinical practice.


Section I. Vascular Surgery
1. Outcomes Following Endovascular vs Open Repair of Abdominal Aortic Aneurysm: The OVER Trial
2. Long Term Outcomes of Immediate Repair Compared with Surveillance of Small Abdominal Aortic Aneurysm
3. Endovascular Aneurysm Repair vs. Open Repair in Patients with Abdominal Aortic Aneurysm: EVAR Trial 1
4. Endovascular Aneurysm Repair and Outcomes in Patients Unfit for Open Repair of Abdominal Aortic Aneurysm: EVAR Trial 2
5. Carotid Endarterectomy for Asymptomatic Carotid Stenosis: The ACST Trial
6. Carotid Endarterectomy for Symptomatic Carotid Stenosis: The NASCET Trial
7. Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis: The Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)
8. Cardiac Stents versus Coronary Artery Bypass Surgery for Severe Coronary Artery Disease: The SYNTAX Trial

Section II. Colorectal Surgery
9. Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer: The Swedish Rectal Cancer Trial
10. A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer: The COST Trial
11. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer: The MOSAIC Trial

Section III. Surgical Outcomes
12. Classification of Surgical Complications: A New Proposal with Evaluation in a Cohort of 6336 Patients and Results of a Survey
13. Multivariable Predictors of Postoperative Surgical Site Infection after General and Vascular Surgery: Results from the Patient Safety in Surgery Study
14. Hospital Volume and Surgical Mortality in the United States
15. Reducing Catheter-Related Bloodstream Infections in the Intensive Care Unit: The Keystone ICU Project
16. The Surgical Safety System Checklist (SURPASS)
17. Proving the Value of Simulation in Laparoscopic Surgery

Section IV. Hernia and Abdomen
18. Watchful Waiting vs. Surgery for Inguinal Hernia
19. Laparoscopic vs. Open Repair of Inguinal Hernia
20. Minimally Invasive Approach to Infected Pancreatic Necrosis
21. Long-Term Impact of Bariatric Surgery

Section V. Surgical Oncology
22. Sentinel Lymph Node Dissection vs. Complete Axillary Dissection in Invasive Breast Cancer: The Z0011 Trial
23. Mastectomy vs. Lumpectomy for Invasive Breast Cancer: The B-06 Trial
24. Breast Cancer after Prophylactic Bilateral Mastectomy in Patients with BRCA Mutation
25. Sentinel Lymph Node Biopsy vs. Nodal Observation in Melanoma
26. Perioperative chemotherapy vs. surgery alone for resectable gastroesophageal cancer (MAGIC Trial)
27. Surgical Treatment of Gastric Cancer: 15-Year Follow-Up Results of the Randomized Nationwide Dutch D1D2 Trial
28. Gastroesophageal Junction Tumors: Does Location Determine Treatment?
29. Gastrointestinal Stromal Tumor Outcomes

Section VI. Trauma and Surgical Critical Care
30. Transfusion Ratios in Trauma
31. Accuracy of Focused Abdominal Sonography for Trauma (FAST)
32. Early vs. Late Tracheostomy for Intubated Patients
33. Femoral vs. Subclavian Central Lines in Critically Ill Patients
34. Early Goal-Directed Therapy in Sepsis
35. Red Cell Transfusion in Critically Ill Patients: The TRICC Trial

Section VII. Minimally Invasive and Bariatric Surgery
36. Laparoscopic vs. Open Appendectomy
37. Laparoscopic Nissen Fundoplication for GERD
38. Outcomes After Laparoscopic Splenectomy
39. Bariatric Surgery vs. Intensive Medical Therapy in Obese Patients with Diabetes (STAMPEDE Trial)
40. Heller myotomy vs. Heller myotomy with Dor fundoplication for Achalasia
41. Bile Duct Injury in Laparoscopic Cholecystectomy: A Persistent Complication

Section VIII. Endocrine Surgery
42. Size as a Predictor of Malignancy of Adrenal Cortical Carcinoma
43. Minimally Invasive Parathyroidectomy vs. Conventional Surgery for Primary Hyperparathyroidism

Section IX. Studies of Historical Interest in Surgery
44. Internal Mammary Artery Ligation vs. Sham Sternotomy for Angina Pectoris
45. Ranson's Criteria for Acute Pancreatitis
46. Timing of Cholecystectomy after Biliary Pancreatitis
47. Child-Pugh score for Mortality in Cirrhosis
48. Hinchey Classification of Acute Diverticulitis
49. Acute Appendicitis
50. Zollinger-Ellison Syndrome


SreyRam Kuy, MD, MHS, FACS serves as Chief Medical Officer for Louisiana Medicaid where she leads the drive to improve healthcare quality in a $10.7 billion health system serving 1.6 million patients, and teaches as Associate Professor of Surgery at LSU-New Orleans. Dr. Kuy earned her master's in health policy and research at Yale as a Robert Wood Johnson Clinical Scholar and has published more than 40 articles on healthcare quality, surgical outcomes and patient safety. Dr. Kuy was selected as a Presidential Leadership Scholar, a joint leadership program by President Clinton and President Bush, Business Report's 40 Under 40 Award, the Ford Foundation's Community Service Award and the Early Career Achievement Award by Oregon Health & Sciences University. Dr. Kuy's writing has appeared in the Los Angeles Times, USA Today, the Washington Post, The Independent, the Huffington Post, and Salon.; Rachel J. Kwon is a graduate of Rush Medical College in Chicago. She trained in general surgery at Maimonides Medical Center in Brooklyn and was a clinical research fellow in evidence-based surgery at the University of Oxford. Currently, she is Chief Medical Consultant at MDCalc and is passionate about evidence-based medicine, physician wellness and furthering the advancement of the underrepresented in medicine, including women, ethnic minorities, and LGBTQ people.; Miguel A. Burch, MD is the Associate Director of Minimally Invasive Surgery and Director of the Minimally Invasive and Bariatric Surgery Fellowship in the Department of Surgery at Cedars Sinai. He has focused his surgical career on benign and malignant diseases that affect the stomach and upper intestinal tract. Dr. Burch is a principal investigator on clinical trials using innovative endoscopic platforms to treat reflux as well as diabetes and obesity.